Skip to main content
. Author manuscript; available in PMC: 2010 Apr 1.
Published in final edited form as: J Nat Prod. 2009 Apr;72(4):732–738. doi: 10.1021/np8007649

Table 3.

Minimum inhibitory activity, MIC (µg/mL) of trisoxazole macrolides against pathogenic Candida and Cryptococcus neoformans strains (positive control, amphotericin B, AMB).

Candida albicans
ATCC 14503
C. glabrata C. neoformans var.
grubii
1 0.016 0.25 0.125
2 0.50 0.50 1.00
3 2.00 1.00 2.00
5 0.250 0.125 0.50
AMB 0.016 0.25 0.016